This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beijing Gingko Group Biological Technology Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Qiaojie Cheng: Innovator in Lingonberry Extract Technologies
Introduction
Qiaojie Cheng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biological technology, particularly through his innovative work on lingonberry extracts. His research focuses on the preparation and applications of these extracts, which have various health benefits.
Latest Patents
Qiaojie Cheng holds 1 patent for his invention titled "Lingonberry extract, methods of preparing, and uses thereof." This patent describes a first extract of lingonberry comprising 5-35 wt % of anthocyanin, 20-95 wt % of proanthocyanin, less than 5 wt % of resveratrol, and the balance of other components. Additionally, it includes a second extract containing 60-98 wt % of resveratrol, and a third extract composed of any ratio of the first and second extracts. The methods for preparing these extracts and their uses in compositions for eliminating oxygen free radicals, anti-aging, weight loss, preventing cardiovascular disease, inhibiting thrombosis, and promoting beauty are also detailed in the patent.
Career Highlights
Qiaojie Cheng is associated with Beijing Ginkgo Group Biological Technology Co., Ltd., where he applies his expertise in biological technology. His work has positioned him as a key figure in the development of health-related products derived from natural sources.
Collaborations
He collaborates with notable colleagues, including Yanmei Li and Xiarui Dou, who contribute to his research and development efforts.
Conclusion
Qiaojie Cheng's innovative work on lingonberry extracts showcases his commitment to advancing health technologies. His contributions have the potential to impact various health-related fields significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile